Evidence map›Paper›PMID 35363476›Full record

ArticleACS infectious diseases2022

Oxadiazon Derivatives Elicit Potent Intracellular Growth Inhibition against

Kerrick C Rees, Zhicheng Dou, Daniel C Whitehead

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Oxadiargyl analogs as potent inhibitors ofRSC medicinal chemistry · 2026
    Article
  3. One-Pot Method to Access 1,3,4-Oxadiazol-2(3The Journal of organic chemistry · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kerrick C ReesDepartment of Chemistry, Clemson University, Clemson, South Carolina 29634, United States.
Zhicheng DouDepartment of Biological Sciences, Clemson University, Clemson, South Carolina 29634, United States.
Daniel C WhiteheadDepartment of Chemistry, Clemson University, Clemson, South Carolina 29634, United States.ORCID 0000-0001-6881-2628
Clemson University · US

Funding

The role of acetate fermentation in Entamoeba histolytica growth and infectionP20GM109094 · NIGMS · CLEMSON UNIVERSITY · PI MORRIS, MEREDITH T · 2016 to 2020
$10.4M
Regulation of the physiology and function of the digestive vacuole in Toxoplasma gondiiR01AI143707 · NIAID · CLEMSON UNIVERSITY · PI DOU, ZHICHENG · 2020 to 2024
$1.8M
NIAID NIH HHS R01 AI143707NIGMS NIH HHS P20 GM109094
6 · The paper itself

Abstract

Infections of

Indexed as

ToxoplasmaHemeHumansOxadiazolesHemeOxadiazolesoxadiazonoxadiargylPPO, oxadiazonprotoporphyrinogen oxidaseToxoplasma gondiitriazole

Identifiers

PMID35363476
PMCPMC9106912
OpenAlexW4220747076

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.